Clinical Trial

Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')

Recruiting
View on ClinicalTrials.gov →
Summary
To demonstrate the safety and efficacy of Orbera365 in obese populations to support the registration of Orbera365.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-06-13
notable Primary completion pushed: 2028-04-30 -> 2028-06-30 2026-05-30
minor Completion pushed: 2028-10-31 -> 2028-12-31 2026-05-30
Trial Details
NCT Number NCT07195708
Lead Sponsor Boston Scientific Corporation
Conditions Weight Loss
Enrollment 144 participants
Start Date 2026-06-03
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-29